drugset / Trial / NCT00002586
13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
RandomizedParallel-groupTriple-blindPrevention
Summary
RATIONALE: 13 Cis retinoic acid may prevent the development of cancer cells. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of 13-cis retinoic acid with or without vitamin E for chemoprevention or observation of cancer in persons at high risk of developing lung cancer.
Timeline
- Start
- 1993-01
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isotretinoin | Other / unclassified | 50 mg | Oral |
| Subject | Vitamin E | Other / unclassified | 800 mg | Oral |